Cepheid Closes $345M Offering of Convertible Senior Notes | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Monday that it has closed its $345 million offering of 1.25 percent convertible senior notes.

The offering includes $300 million of notes that were sold to qualified institutional investors and $45 million of notes that were issued pursuant to the exercise of an overallotment option by the notes' initial purchasers, Morgan Stanley and Jefferies. The notes are due in 2021.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.